IDO1 and type 2 diabetes mellitus: In general, the KYN pathway is more activated in an inflammatory environment, as exists in type 2 diabetes, resulting in upregulation of indoleamine 2,3-dioxygenase (IDO) [11] by cytokines (primarily IFN-γ).